Monitoring vaccine safety: A critical component of every immunisation program

Medical Journal of Australia

Volumn 189, Issue 5, 2008, Pages 243-244

  Brotherton, Julia M L ^a   Gold, Michael S ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; ROTAVIRUS VACCINE; VACCINE; WART VIRUS VACCINE;

ACUTE PANCREATITIS; AUSTRALIA; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DRUG SAFETY; EDITORIAL; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; INFORMATION DISSEMINATION; INTUSSUSCEPTION; POSTMARKETING SURVEILLANCE; VACCINATION;

FEMALE; HUMANS; MASS VACCINATION; PAPILLOMAVIRUS VACCINES; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 53349117170     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb02012.x     Document Type: Editorial

References (10)

1. Therapeutic Goods Administration. Human papillomavirus vaccine (Gardasil). Advice from the Therapeutic Goods Administration. http://www.tga.gov.au/alerts/medicines/gardasil.htm (accessed Jul 2008).
2. McIntyre P, Leask J. Improving uptake of MMR vaccine, BMJ 2008; 336: 729-730.
3. Buttery JP, Madin S, Crawford NW, et al. Mass psychogenic response to human papillomavirus vaccination. Med J Aust 2008; 189: 261-262.
4. Smith MA, Canfell K, Brotherton JM, et al. The predicted impact of vaccination on human papillomavirus infections in Australia. Int J Cancer 20013; July 17 [Epub ahead of print]. DOI: 10.1002/ijc.23633.
5. Das A, Chang D, Biankin AV, Merrett ND, Pancreatitis following human papillomavirus vaccination [letter]. Med J Aust 2008; 189: 178.
6. Australian Institute of Health and Welfare. Separation, patient day and average length of stay statistics by principal diagnosis in ICD-10-AM, Australia, 1998-99 to 2004-05. http://www.aihw.gov.au/cognos/cgi-bin/ ppdscgi?DC=Q&E=/ahs/principaldiagnosis9899-0405 (accessed May 2008).
7. Kramarz F, France EK, Destefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 2001; 20: 410-416.
8. Murphy TV, Gargiullo PM, Massoudi MS, et al; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rota-virus vaccine. N Engl J Med 2001; 344: 564-572.
9. US Centers for Disease Control and Prevention. CDC WONDER online database. Vaccine Adverse Event Reporting System (VAERS) request. http://wonder.cdc.gov/vaers.html (accessed Jul 2008).
10. Leask J. Vaccination and risk communication: summary of a workshop, Arlington Virginia, USA, 5-6 October 2000. J Paediatr Child Health 2002; 38: 124-128.